𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Autosomal dominant paroxysmal kinesigenic choreoathetosis

✍ Scribed by Busard, H.L.S.M.; Renier, W.O.; Gabreëls, F.J.M.; Vos, A.J.M.; Declerck, A.C.; Verhey, F.H.M.

Book ID
121889389
Publisher
Elsevier Science
Year
1984
Tongue
English
Weight
964 KB
Volume
86
Category
Article
ISSN
0303-8467

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topiramate therapy for paroxysmal kinesi
Topiramate therapy for paroxysmal kinesigenic choreoathetosis
✍ Yuan-Gui Huang; Yun-Chun Chen; Fang Du; Rui Li; Ge-Lin Xu; Wen Jiang; Jing Huang 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

## Abstract We observed the clinical efficacy of topiramate for paroxysmal kinesigenic choreoathetosis (PKC). Topiramate was administered as a monotherapy with titrated dosages to 8 patients with PKC. Target daily dose of topiramate was 100 to 200 mg; the follow‐up period ranged from 8 months to 2